This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
Stem Cell Research & Therapy Open Access 24 January 2023
-
Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis
Stem Cell Research & Therapy Open Access 07 June 2022
-
Tissue engineering in age-related macular degeneration: a mini-review
Journal of Biological Engineering Open Access 16 May 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chakradhar, S. An eye to the future: Researchers debate best path for stem cell–derived therapies. Nat Med 22, 116–119 (2016). https://doi.org/10.1038/nm0216-116
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0216-116
This article is cited by
-
Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
Stem Cell Research & Therapy (2023)
-
Challenges in the clinical advancement of cell therapies for Parkinson’s disease
Nature Biomedical Engineering (2023)
-
Tissue engineering in age-related macular degeneration: a mini-review
Journal of Biological Engineering (2022)
-
Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis
Stem Cell Research & Therapy (2022)
-
Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension
Scientific Reports (2021)